25-04-2025
Carterra Announces its 2025 Symposia Series on Speeding Drug Discovery with AI/ML and Other New Technologies
SALT LAKE CITY, April 25 (Bernama) -- Carterra Inc., the world leader in enabling high-throughput biology, is partnering with co-hosts ImmunoPrecise Antibodies (IPA), ACROBiosystems, and Curia to offer its 2025 symposia series titled, 'Unlocking High-Throughput Biology in Drug Discovery.' The series will feature four, one-day events across key cities in the U.S. and Europe. The event locations and dates are as follows:
May 6, 2025: Boston, Massachusetts, USA
June 4, 2025: Munich, Germany
June 6, 2025: Cambridge, United Kingdom
June 24, 2025: San Francisco, California, USA
The symposia are tailored for the drug discovery scientist. Topics will cover antibody and large molecule through small molecule discovery, including cutting-edge areas such as machine learning and AI approaches for protein engineering, emerging oncology targets, engineering of bispecific and multifunctional antibodies, library generation, biophysical characterization, and high-definition epitope binning to enable novel biotherapeutics, among others.
